This inventor holds 1 USPTO granted patent. Top assignee: Monogram Biosciences, Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Thomas Klopack: Innovator in Biomarker Detection
Introduction
Thomas Klopack is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of biomarker detection, particularly in the context of cancer research. His innovative approach focuses on detecting biomarkers in rare circulating cells, which is crucial for advancing cancer diagnostics.
Latest Patents
Klopack holds a patent for a method of detecting biomarkers in circulating cells. This method involves forming an enriched population of cells immunomagnetically, followed by biomarker detection using binding compounds that have releasable molecular tags. Specifically, the patent addresses the detection of biomarkers comprising one or more protein-protein complexes in circulating cancer cells that have metastasized from solid tumors. In the presence of these biomarkers, the molecular tags of the binding compounds are released and separated from the assay mixture for detection and quantification. This innovative technique has the potential to enhance the accuracy of cancer diagnostics.
Career Highlights
Klopack is currently associated with Monogram Biosciences, Inc., where he continues to work on advancing biomarker detection technologies. His expertise in this area has positioned him as a valuable asset in the field of cancer research and diagnostics.
Collaborations
Some of his notable coworkers include Hrair Kirakossian and Sharat Singh. Their collaborative efforts contribute to the ongoing research and development in biomarker detection.
Conclusion
Thomas Klopack's work in biomarker detection represents a significant advancement in cancer diagnostics. His innovative methods and collaborations with other experts in the field continue to push the boundaries of what is possible in medical research.